(Q28263865)

https://api.crossref.org/works/10.1038%2FNRI1936

The three Es of cancer immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

The immunobiology of cancer immunosurveillance and immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Roles of the NKG2D immunoreceptor and its ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

A novel dendritic cell subset involved in tumor immunosurveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Autoantibody signatures in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

p53 autoantibodies predict subsequent development of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Evaluation of anticyclin B1 serum antibody as a diagnostic and prognostic biomarker for lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immune response against dying tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Post-transplant malignancy: the role of immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Increased incidence of melanoma in renal transplantation recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

A proportion of patients with lymphoma may harbor mutations of the perforin gene.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Perspectives on cancer immuno-epidemiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Intrinsic tumour suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

NKG2D function protects the host from tumor initiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Soluble MICA in malignant diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Oncogene-induced senescence as an initial barrier in lymphoma development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Spinning molecular immunology into successful immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Tumour biology: senescence in premalignant tumours

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

A critical function for type I interferons in cancer immunoediting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Transforming growth factor-beta in T-cell biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

The pathophysiology of mitochondrial cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Death receptors in chemotherapy and cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Caspase-independent cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Spontaneous immunity against Bcl-xL in cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Tumor counterattack: fact or fiction?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Versatile prostate cancer treatment with inducible caspase and interleukin-12.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Tumor-host immune interactions and dendritic cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

COX-2: a molecular target for colorectal cancer prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Lysosomes and autophagy in cell death control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immunological ignorance of solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Regulation of immune responses by L-arginine metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Turning on/off tumor-specific CTL response during progressive tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immunosuppressive networks in the tumour environment and their therapeutic relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immunoregulatory T cells in tumor immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Autoantigens act as tissue-specific chemoattractants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

The role of dendritic cell precursors in tumour vasculogenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Targeting apoptosis pathways in cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRI1936